Rutinib Cream (RUXOLITINIB 1.5%)

Rating:
Brand:
Available: In stock
150 $
+

Buy Rutinib RUXOLITINIB at a favorable price from India - generic Opzelura

Rutinib Cream (RUXOLITINIB 1.5%) is a topical cream containing ruxolitinib 1.5%. It belongs to the group of Janus kinase (JAK) inhibitors and is used in dermatology when a doctor needs a targeted local effect on inflammatory processes in the skin.

Rutinib may be considered as a generic alternative to Opzelura for patients who have been prescribed ruxolitinib cream. Before ordering, check the trade name, concentration, 30 g tube format and the exact application schedule recommended by your physician. The information on this page is for reference only and does not replace medical advice.

Indications for use

Ruxolitinib cream is used internationally for selected chronic skin conditions where the JAK-STAT signaling pathway is clinically relevant. The diagnosis, treatment area and duration of therapy must be determined by a healthcare professional.

  1. Mild to moderate atopic dermatitis in patients who did not respond adequately to other prescription topical therapies or for whom such options are not suitable.
  2. Non-segmental vitiligo in adults and adolescents when prescribed by a specialist.
  3. Inflammatory skin symptoms such as itching, redness and irritation when ruxolitinib therapy is considered appropriate by a doctor.

How RUXOLITINIB 1.5% works

RUXOLITINIB inhibits JAK1/JAK2-dependent signaling pathways involved in the transmission of inflammatory cytokine signals. Because it is applied directly to the skin, the active ingredient acts mainly in the treated area, making the cream a convenient option for limited skin lesions.

The effect should not be viewed as immediate or guaranteed. In atopic dermatitis, a doctor usually monitors changes in itching, redness and irritation. In vitiligo, improvement develops gradually and requires regular assessment of progress.

Directions for use

The cream is intended for external use only. It must not be taken orally, applied to the eyes, mucous membranes or any area not specified by a doctor. Do not increase the frequency of application or the treatment area on your own.

  1. Clean and dry the affected skin area before application.
  2. Apply a thin layer only to the areas indicated by your doctor.
  3. Wash your hands after use unless the cream is intended for the skin of the hands.
  4. Do not cover treated areas with an occlusive dressing unless directly instructed.
  5. Contact your doctor if irritation becomes worse or signs of infection appear.

Contraindications and precautions

Rutinib Cream should not be used in case of hypersensitivity to ruxolitinib or any excipient. Caution is required in patients with active infections, weakened immunity, a history of malignancy, thrombosis, cardiovascular risk factors, pregnancy or breastfeeding.

Do not combine the product with systemic JAK inhibitors, biologic therapies or strong immunosuppressants without medical supervision. Fever, painful eruptions, marked deterioration, shortness of breath, chest pain or unusual bleeding require urgent medical consultation.

Possible side effects

Local reactions may include irritation, redness, itching, dry skin, folliculitis or acne-like lesions. Headache or signs of infection in the application area may also occur. Any reaction should be assessed in the context of the diagnosis, treated surface area and concomitant therapy.

If you plan to buy Rutinib RUXOLITINIB at a favorable price from India, make sure first that the product has been prescribed and is appropriate for your clinical situation. A manager can clarify availability, delivery terms and packaging, but the treatment regimen must be selected only by a healthcare professional.

No comments
Write a comment
Name*
E-mail
Enter a comment*